The role of nateglinide and repaglinide, derivatives of meglitinide, in the treatment of type 2 diabetes mellitus.
about
Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus.Pharmacokinetic and pharmacodynamic modeling of oral mitiglinide on glucose lowering in healthy Chinese volunteersA variant of PSMD6 is associated with the therapeutic efficacy of oral antidiabetic drugs in Chinese type 2 diabetes patients.Effects of nateglinide and rosiglitazone on pancreatic alpha- and beta-cells, GLP-1 secretion and inflammatory markers in patients with type 2 diabetes: randomized crossover clinical study.Exendin-4 enhances expression of Neurod1 and Glut2 in insulin-producing cells derived from mouse embryonic stem cells.Increased chitotriosidase activity in plasma of patients with type 2 diabetesPharmacogenomics of glinides.Pharmacological Management of Gestational Diabetes Mellitus.A review of glucagon-like peptide-1 receptor agonists and their effects on lowering postprandial plasma glucose and cardiovascular outcomes in the treatment of type 2 diabetes mellitus.Progressing From Metformin to Sulfonylureas or Meglitinides.Impact of the use of anti-diabetic drugs on survival of diabetic dialysis patients: a 5-year retrospective cohort study in Taiwan.Lipid-lowering and anti-inflammatory effects of omega 3 ethyl esters and krill oil: a randomized, cross-over, clinical trial.Meglitinides increase the risk of hypoglycemia in diabetic patients with advanced chronic kidney disease: a nationwide, population-based study.Glycemic control and safety in Chinese patients with type 2 diabetes mellitus who switched from premixed insulin to insulin glargine plus oral antidiabetics: a large, prospective, observational study.One-pot borylation/Suzuki-Miyaura sp2-sp3 cross-coupling.Enhancement of solubility and antidiabetic effects of Repaglinide using spray drying technique in STZ-induced diabetic rats.Characteristics of repaglinide and its mechanism of action on insulin secretion in patients with newly diagnosed type-2 diabetes mellitus
P2860
Q30249371-49F29086-56DA-4390-A2BB-DCD76CECEE2AQ33869446-DCA9637A-9380-4EF5-9725-63AB46A64B1EQ35664025-FBC6D0A9-192F-41FF-A61E-721010E7E669Q36428446-4DD25AC3-D791-48C7-A3DF-1ACE9568B92BQ36582408-28F246AF-40B3-4C89-A409-522F4A443C09Q37243033-3262AD5F-4186-48D4-9B22-2F86DA117AA6Q38307994-7ED2BBF5-F48C-4C51-84A3-7992F57F021BQ38597073-C9B66CF4-78D8-43B7-A67C-1B9C27972BB9Q38802810-D89A1268-A4E1-4565-8FA4-066574C7B148Q38952882-327E31A9-D0ED-4729-A534-D16284C99D9BQ39418202-A0EF6705-2F7C-4CCC-BA7C-9B356F86481CQ42130332-A734A233-B449-4E8F-BB29-F6002FA4D72EQ47145533-2BCB1C87-2D8B-491F-9561-5CEC431CF206Q51278671-9F12CE62-DCFE-4294-B353-39A3E9C729D2Q53120950-C4A43EE6-493D-40FA-BC96-945F410A055DQ53170539-50A8756C-D762-4E68-BF37-2FC8D61F8CADQ58703936-3B366BDC-DB76-4F93-A79B-444216009001
P2860
The role of nateglinide and repaglinide, derivatives of meglitinide, in the treatment of type 2 diabetes mellitus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of nateglinide and re ...... t of type 2 diabetes mellitus.
@en
The role of nateglinide and re ...... t of type 2 diabetes mellitus.
@nl
type
label
The role of nateglinide and re ...... t of type 2 diabetes mellitus.
@en
The role of nateglinide and re ...... t of type 2 diabetes mellitus.
@nl
prefLabel
The role of nateglinide and re ...... t of type 2 diabetes mellitus.
@en
The role of nateglinide and re ...... t of type 2 diabetes mellitus.
@nl
P2093
P2860
P356
P1476
The role of nateglinide and re ...... nt of type 2 diabetes mellitus
@en
P2093
Annamaria Prioletta
Aravind Sosale
Lilia M Jiménez-Ceja
Rodolfo Guardado-Mendoza
P2860
P304
P356
10.5114/AOMS.2013.34991
P50
P577
2013-04-30T00:00:00Z